Stellenangebote für Clinical Development Project M Jobs in Augsburg

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted

11.04.24 | Vollzeit | Augsburg | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted